Devonian Health Group Inc (GSD_CDNX)
News Quantified tracks GSD_CDNX headlines — 74 labeled events over the last three years — but too few produced usable price reactions to publish stable medians. The events themselves are below.
Not enough usable reactions to publish GSD_CDNX medians.
74 GSD_CDNX events are labeled, but too few carry a measurable price reaction for a median to mean anything. When enough reactions accumulate, the medians publish here the same way as every other name.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when GSD_CDNX moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to GSD_CDNX's baseline. Nothing else.
Recent GSD_CDNX events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Devonian Health Group Provides Update on its Planned NYSE American Listing | Press release | Canada Newswire | — | — | |
| Devonian Health Group Inc. Anticipates to Commence Trading on the NYSE American | Press release | PR Newswire | — | — | |
| Devonian Health Group Strengthens Thykamine™ Manufacturing Platform with Validated Chemical-Composition Fingerprinting and Biological Potency Assay | Press release | Canada Newswire | — | — | |
| Devonian Health Group Anticipates to Commence Trading on the NYSE American | Press release | PR Newswire | — | — | |
| Devonian Health Group Announces Proposed Listing on the NYSE American with Concurrent Underwritten Public Offering | Press release | Canada Newswire | — | — | |
| Devonian Health Group Receives Health Canada Authorization to Initiate Phase II/III Pediatric Clinical Trial of Thykamine™ for Mild-to-Moderate Atopic Dermatitis in Patients Aged 3 Months to 17 Years | Press release | Canada Newswire | — | — | |
| Devonian Health Group Reports Financial and Operating Results of its Three and Nine Months Ended April 30, 2026 | Press release | Canada Newswire | — | — | |
| Devonian Reports Results of its Annual General and Special Meeting of Shareholders | Press release | Canada Newswire | — | — | |
| Devonian Health Group Inc. Reports Financial and Operating Results of its Three and Six Months Ended January 31, 2026 | Press release | PR Newswire | — | — | |
| Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine™, with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects | Press release | PR Newswire | — | — | |
| Devonian Advances Thykamine™ Patent Strategy with Proprietary Fingerprint and Robust Manufacturing Controls | Press release | PR Newswire | — | — | |
| Devonian reports additional molecular data from MASH liver study | Press release | PR Newswire | — | — | |
| DEVONIAN REPORTS POSITIVE RESULTS IN PULMONARY FIBROSIS STUDY | Press release | Canada Newswire | — | — | |
| DEVONIAN APPOINTS DENNIS TURPIN AS CHIEF FINANCIAL OFFICER AND PROVIDES UPDATES ON STOCK OPTIONS GRANT | Press release | PR Newswire | — | — | |
| DEVONIAN ANNOUNCES SHARE CONSOLIDATION IN FURTHER PREPARATION FOR POTENTIAL U.S. LISTING | Press release | PR Newswire | — | — | |
| Devonian Health Group Announces Grant of Stock Options | Press release | PR Newswire | — | — | |
| Devonian Health Group Reports Financial Results of its First Quarter Ended on October 31, 2025 and Provides Corporate Update | Press release | Canada Newswire | — | — | |
| Devonian Health Group Announces Publication of Landmark Study Highlighting Thykamine™ as a Promising New Anti-Inflammatory Agent | Press release | PR Newswire | — | — | |
| Devonian Health Group Reports its Fourth Quarter and Annual 2025 Financial Results and Appointment of a New Board Member | Press release | PR Newswire | — | — | |
| Devonian Health Group Inc. announces its participation to the ThinkEquity Conference in New York and closing of a Non-Brokered Private Placement of Units | Press release | PR Newswire | — | — | |
| Devonian Provides Corporate Update and Additional Information Regarding its Previously Announced Private Placement | Press release | Business Wire | — | — | |
| Devonian Announces Closing of a Private Placement of Units | Press release | Business Wire | — | — | |
| Devonian Health Group Reports Third Quarter 2025 Financial Results | Press release | Business Wire | — | — | |
| Devonian Appoints New Officers and Announces Grant of Stock Options | Press release | Business Wire | — | — | |
| Canadian Investment Regulatory Organization Trade Resumption - GSD | Press release | Canada Newswire | — | — | |
| Devonian Health Group Announces Reinstatement of Quotation on the TSXV | Press release | Business Wire | — | — | |
| Devonian Health Group Reports Second Quarter 2025 Financial Results | Press release | Business Wire | — | — | |
| Devonian Health Group Reports Cease Trade Order | Press release | Business Wire | — | — | |
| Canadian Investment Regulatory Organization Trading Halt - GSD | Press release | Canada Newswire | — | — | |
| Devonian Reports Delay of Financial Reporting | Press release | Business Wire | — | — | |
| Devonian Reports Results of its Annual General and Special Meeting of Shareholders | Press release | Business Wire | — | — | |
| Devonian Announces the Filing of a New Patent Application Relating to the Use of Thykamine™ as an Antifibrotic Agent | Press release | Business Wire | — | — | |
| Devonian Announces Positive in Vivo Results of Thykamine™ on Gene Expression Associated With Fibrosis | Press release | Business Wire | — | — | |
| Devonian Announces the Filing of a New Provisional Patent Application Relating to the Use of Thykamine™ for Treating Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Press release | Business Wire | — | — | |
| Devonian Reports Positive Results in MASH Liver Study | Press release | Business Wire | — | — | |
| Devonian Reports Distribution Agreement Termination | Press release | Business Wire | — | — | |
| Devonian Health Group Inc. Reports Superior Anti-Inflammatory Potency of Thykamine™ in Comparative In Vitro Study | Press release | Business Wire | — | — | |
| Devonian Appoints Viktoria Krasteva as Chief Financial Officer | Press release | Business Wire | — | — | |
| Devonian Health Group Reports First Quarter 2025 Financial Results and Grants Stock Options | Press release | Business Wire | — | — | |
| Devonian Reports Its Annual 2024 Financial Results | Press release | Business Wire | — | — | |
| Devonian Announces the Grant of Stock Options | Press release | Business Wire | — | — | |
| Devonian Announces Amendment to its Articles of Amalgamation and Resignation of its Interim Chief Financial Officer | Press release | Business Wire | — | — | |
| Devonian Health Group to Participate in Renmark’s Chicago Virtual Non-Deal Roadshow Series on Wednesday, July 17, 2024 | Press release | Business Wire | — | — | |
| Devonian Health Group to Participate in Renmark’s Los Angeles Virtual Non-Deal Roadshow Series on Wednesday, July 10, 2024 | Press release | Business Wire | +0.00% | +0.00% | |
| Devonian Health Group Reports Third Quarter 2024 Financial Results and Business Update and Announces Engagement of Investor Relations Firm | Press release | Business Wire | +0.00% | +30.00% | |
| Devonian Health Group to Participate in Renmark’s Boston Virtual Non-Deal Roadshow Series on Wednesday, June 26, 2024 | Press release | Business Wire | +0.00% | +30.00% | |
| Devonian Appoints André P. Boulet to Chairman of the Board and Chief Operating Officer | Press release | Business Wire | — | — | |
| Devonian Health Group Reports Second Quarter 2024 Financial Results and Business Update | Press release | Business Wire | +0.00% | +0.00% | |
| Devonian Announces Closing of a Private Placement of Units | Press release | Business Wire | +0.00% | +0.00% | |
| Devonian Names Kathryn J. Gregory to the Board of Directors and Grants Stock Options | Press release | Business Wire | +0.00% | +0.00% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the GSD_CDNX section they belong to.
Where else GSD_CDNX is measured.
GSD_CDNX earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| VITALIBIS INC (VCBD) | 76 | 0.00% | 25% |
| TherapeuticsMD, Inc. (TXMD) | 75 | +0.32% | 57% |
| MAPLE LEAF GREEN WRLD INC (MGWFF) | 74 | 0.00% | 44% |
| BIOASIS TECHNOLOGIES INC (BIOAF) | 73 | 0.00% | 20% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.